Bone marrow concentrate for autologous transplantation in minipigs: Characterization and osteogenic potential of mesenchymal stem cells

Veterinary and Comparative Orthopaedics and Traumatology

Volumn 26, Issue 1, 2013, Pages 34-41

  Herten, M ^a   Grassmann, Jan P ^a   Sager, M ^a   Benga, L ^a   Fischer, J C ^a   Jager M ^b   Betsch, M ^a   Wild, M ^a   Hakimi, M ^a   Jungbluth, P ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Bone marrow concentrate; Colony forming units; Mesenchymal stem cells; Minipig

Indexed keywords

BIOLOGICAL MARKER;

ANIMAL; ANIMAL DISEASE; ARTICLE; BONE DEVELOPMENT; BONE MARROW; BONE MARROW TRANSPLANTATION; BONE REGENERATION; CELL PROLIFERATION; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STROMA CELL; METHODOLOGY; MINIPIG; PHYSIOLOGY; STAINING; SWINE;

ANIMALS; BIOLOGICAL MARKERS; BONE MARROW; BONE MARROW TRANSPLANTATION; BONE REGENERATION; CELL PROLIFERATION; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STROMAL CELLS; OSTEOGENESIS; STAINING AND LABELING; SWINE; SWINE, MINIATURE;

SUS;

EID: 84875726168     PISSN: 09320814     EISSN: None     Source Type: Journal    
DOI: 10.3415/VCOT-11-11-0165     Document Type: Article

References (39)

1. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315-317.
2. Friedenstein AJ, Petrakova KV, Kurolesova AI, et al. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 1968; 6: 230-247.
3. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997; 276: 71-74.
4. Caplan AI. Mesenchymal stem cells. J Orthop Res 1991; 9: 641-650.
5. Haynesworth SE, Goshima J, Goldberg VM, et al. Characterization of cells with osteogenic potential from human marrow. Bone 1992; 13: 81-88.
6. Bennett JH, Joyner CJ, Triffitt JT, et al. Adipocytic cells cultured from marrow have osteogenic potential. J Cell Sci 1991; 99: 131-139.
7. Beresford JN, Bennett JH, Devlin C, et al. Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J Cell Sci 1992; 102: 341-351.
8. Yoo JU, Barthel TS, Nishimura K, et al. The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg Am 1998; 80: 1745-1757.
9. Johnstone B, Hering TM, Caplan AI, et al. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 1998; 238: 265-272.
10. Wakitani S, Saito T, Caplan AI. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 1995; 18: 1417-1426.
11. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41-49.
12. Kawada H, Fujita J, Kinjo K, et al. Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood 2004; 104: 3581-3587.
13. Young RG, Butler DL, Weber W, et al. Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair. J Orthop Res 1998; 16: 406-413.
14. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006; 98: 1076-1084.
15. Le Blanc K. Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy 2003; 5: 485-489.
16. da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all postnatal organs and tissues. J Cell Sci 2006; 119: 2204-2213.
17. Bianco P, Riminucci M, Gronthos S, et al. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 2001; 19: 180-192.
18. Connolly JF, Guse R, Tiedeman J, et al. Autologous marrow injection as a substitute for operative grafting of tibial nonunions. Clin Orthop Relat Res 1991: 259-270.
19. Jäger M, Hernigou P, Zilkens C, et al. Cell therapy in bone healing disorders. Orthop Rev 2010; 2: 79-87.
20. Owen ME, Cave J, Joyner CJ. Clonal analysis in vitro of osteogenic differentiation of marrow CFU-F. J Cell Sci 1987; 87: 731-738.
21. Castro-Malaspina H, Gay RE, Resnick G, et al. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 1980; 56: 289-301.
22. Hernigou P, Poignard A, Beaujean F, et al. Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. J Bone Joint Surg Am 2005; 87: 1430-1437.
23. Solchaga LA, Penick KJ, Welter JF. Chondrogenic differentiation of bone marrow-derived mesenchymal stem cells: tips and tricks. Methods Mol Biol 2011; 698: 253-278.
24. Wheeler DL, Cross AR, Eschbach EJ, et al. Grafting of massive tibial subchondral bone defects in a caprine model using beta-tricalcium phosphate versus autograft. J Orthop Trauma 2005; 19: 85-91.
25. Eley KA, Witherow H, Hayward R, et al. The evaluation of bony union after frontofacial distraction. J Craniofac Surg 2009; 20: 275-278.
26. Jungbluth P, Hakimi M, Grassmann, P, et al. The progress of early phase bone healing using porous granules produced from calcium phosphate cement. Eur J Med Res 2010; 15: 196-203.
27. Jungbluth P, Wild M, Grassmann JP, et al. Plateletrich plasma on calcium phosphate granules promote metaphyseal bone healing in mini-pigs. J Orthop Res 2010; 28: 1448-1455
28. Hakimi M, Jungbluth P, Sager M, et al. Combined use of platelet-rich plasma and autologous bone grafts in the treatment of long bone defects in mini-pigs. Injury 2010; 41: 717-723.
29. Thoesen MS, Berg-Foels WS, Stokol T, et al. Use of a centrifugation-based, point-of-care device for production of canine autologous bone marrow and platelet concentrates. Am J Vet Res 2006; 67: 1655-1661.
30. Jäger M, Herten M, Fochtmann U, et al. Bridging the gap: Bone marrow aspiration concentrate reduces autologous bone grafting in osseous defects. J Orthop Res 2011; 29: 173-180.
31. Hermann PC, Huber SL, Herrler T, et al. Concentration of bone marrow total nucleated cells by a point-of-care device provides a high yield and preserves their functional activity. Cell Transplant 2008; 16: 1059-1069.
32. Agay D, Scherthan H, Forcheron F, et al. Multipotent mesenchymal stem cell grafting to treat cutaneous radiation syndrome: development of a new minipig model. Exp Hematol 2010; 38: 945-956.
33. Chang C, Niu D, Zhou H, et al. Mesenchymal stroma cells improve hyperglycemia and insulin deficiency in the diabetic porcine pancreatic microenvironment. Cytotherapy 2008; 10: 796-805.
34. Muschler GF, Nitto H, Boehm CA, et al. Age- and gender-related changes in the cellularity of human bone marrow and the prevalence of osteoblastic progenitors. J Orthop Res 2001; 19: 117-125.
35. Janicki P, Boeuf S, Steck E, et al. Prediction of in vivo bone forming potency of bone marrow-derived human mesenchymal stem cells. Eur Cell Mater 2011; 21: 488-507.
36. Seeger FH, Tonn T, Krzossok N, et al. Cell isolation procedures matter: a comparison of differ ent isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. Eur Heart J 2007; 28766-772.
37. Turan RG, Bozdag-Turan I, Ortak J, et al. Improvement of cardiac function by intracoronary freshly isolated bone marrow cells transplantation in patients with acute myocardial infarction. Circ J 2011; 75: 683-691.
38. Iba O, Matsubara H, Nozawa Y, et al. Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs. Circulation 2002; 106: 2019-2025
39. Massberg S, Konrad I, Schurzinger K, et al. Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J Exp Med 2006; 203: 1221-1233.